http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20040025891-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-426 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426 |
filingDate | 2002-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2004-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-20040025891-A |
titleOfInvention | Halogen compounds having thrombopoietin receptor agonism |
abstract | The present invention relates to a compound represented by the following general formula (III), a prodrug thereof, a pharmaceutically acceptable salt thereof or a solvate thereof having thrombopoietin agonism:n n n [Compound III]n n n n n n n n [Wherein, R 9 represents hydrogen, lower alkyl which may be substituted, and the like; R 10 , R 11 and R 12 independently represent alkyl, halogeno and the like, which may each be substituted; Each R 14 independently represents lower alkyl, halogeno and the like; n is an integer from 0 to 2; Ring A 3 is a group represented by the formula:n n n [Formula II]n n n n n n n n Wherein R 13 represents hydrogen or lower alkyl; T represents oxygen or sulfur}]. |
priorityDate | 2001-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 140.